Embolization is a minimally invasive treatment procedure that blocks one or more blood vessels or abnormal vascular channels. Embolization procedure requires various types of embolization particles such as radioembolization spheres, drug-eluting beads, microspheres, PVA particles (Polyvinyl Alcohol), and other products such as liquid embolic, plugs, and coils. Embolization procedure is used in the treatment of various chronic diseases such as cancer, uterine fibroid, and other complications of chronic diseases.
Market Dynamics
The academic and research institutes are focusing on the research and development in embolization PVA particles (polyvinyl alcohol), which is expected to drive the market growth over the forecast period
For instance, in April 2019, Washington University School of Medicine, a research university in the U.S., initiated the clinical trial study on Middle Meningeal Artery Embolization with polyvinyl alcohol particles (PVA) on August 2019 and the clinical trial study is expected to be completed by January 1, 2022
Key features of the study:
- This report provides in-depth analysis of the global embolization market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global embolization market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global embolization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global embolization market
Detailed Segmentation:
- Global Embolization Market, By Product Type:
- Particles
- Radioembolization Spheres
- Drug-eluting Beads
- Microspheres (or Blands beads, without drug)
- PVA particles (Polyvinyl Alcohol)
- Liquid Embolic
- Plugs
- Coils
- Global Embolization Market, By Indication:
- Hemorrage/Bleeding
- Benign Prostatic Hyperplasia (BPH)
- Uterine Fibroid
- Tumor (Malignant, including Liver Cancer)
- Malformation (AVM, AVF)
- Venous embolization (incl. Varicocele for ex)
- Others
- Global Embolization Market, By End User:
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- Global Embolization Market, By Region:
- North America
- By Product Type
- Particles
- Radioembolization Spheres
- Drug-eluting Beads
- Microspheres (or Blands beads, without drug)
- PVA particles (Polyvinyl Alcohol)
- Liquid Embolic
- Plugs
- Coils
- By Indication
- Hemorrage/Bleeding
- Benign Prostatic Hyperplasia (BPH)
- Uterine Fibroid
- Tumor (Malignant, including Liver Cancer)
- Malformation (AVM, AVF)
- Venous embolization (incl. Varicocele for ex)
- Others
- By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- By Country
- Latin America
- By Product Type
- Particles
- Radioembolization Spheres
- Drug-eluting Beads
- Microspheres (or Blands beads, without drug)
- PVA particles (Polyvinyl Alcohol)
- Liquid Embolic
- Plugs
- Coils
- By Indication
- Hemorrage/Bleeding
- Benign Prostatic Hyperplasia (BPH)
- Uterine Fibroid
- Tumor (Malignant, including Liver Cancer)
- Malformation (AVM, AVF)
- Venous embolization (incl. Varicocele for ex)
- Others
- By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type
- Particles
- Radioembolization Spheres
- Drug-eluting Beads
- Microspheres (or Blands beads, without drug)
- PVA particles (Polyvinyl Alcohol)
- Liquid Embolic
- Plugs
- Coils
- By Indication
- Hemorrage/Bleeding
- Benign Prostatic Hyperplasia (BPH)
- Uterine Fibroid
- Tumor (Malignant, including Liver Cancer)
- Malformation (AVM, AVF)
- Venous embolization (incl. Varicocele for ex)
- Others
- By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type
- Particles
- Radioembolization Spheres
- Drug-eluting Beads
- Microspheres (or Blands beads, without drug)
- PVA particles (Polyvinyl Alcohol)
- Liquid Embolic
- Plugs
- Coils
- By Indication
- Hemorrage/Bleeding
- Benign Prostatic Hyperplasia (BPH)
- Uterine Fibroid
- Tumor (Malignant, including Liver Cancer)
- Malformation (AVM, AVF)
- Venous embolization (incl. Varicocele for ex)
- Others
- By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type
- Particles
- Radioembolization Spheres
- Drug-eluting Beads
- Microspheres (or Blands beads, without drug)
- PVA particles (Polyvinyl Alcohol)
- Liquid Embolic
- Plugs
- Coils
- By Indication
- Hemorrage/Bleeding
- Benign Prostatic Hyperplasia (BPH)
- Uterine Fibroid
- Tumor (Malignant, including Liver Cancer)
- Malformation (AVM, AVF)
- Venous embolization (incl. Varicocele for ex)
- Others
- By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type
- Particles
- Radioembolization Spheres
- Drug-eluting Beads
- Microspheres (or Blands beads, without drug)
- PVA particles (Polyvinyl Alcohol)
- Liquid Embolic
- Plugs
- Coils
- By Indication
- Hemorrage/Bleeding
- Benign Prostatic Hyperplasia (BPH)
- Uterine Fibroid
- Tumor (Malignant, including Liver Cancer)
- Malformation (AVM, AVF)
- Venous embolization (incl. Varicocele for ex)
- Others
- By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- IMBiotechnologies Ltd. *
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ABK Biomedical Inc.
- EmboMedics
- Guerbet
- Boston Scientific Corporation
- Medtronic Plc.
- Varian Medical Systems, Inc.
- Terumo Corporation
- Merit Medical Systems, Inc.
- Cook Group
- Johnson & Johnson
“*” marked represents similar segmentation in other categories in the respective section.